Results 161 to 170 of about 7,470 (208)
Some of the next articles are maybe not open access.

Antimuscarinics for treatment of overactive bladder

The Lancet Neurology, 2004
For many years, antimuscarinic drugs have been the first-line pharmacological treatment for urgency, frequency, and urge incontinence, all symptoms of the disorder termed overactive bladder. Antimuscarinic treatment is not always effective and is associated with side-effects that limit its clinical use.
openaire   +2 more sources

Antimuscarinic Agents as Substances of Abuse

Journal of Clinical Psychopharmacology, 1988
Centrally active antimuscarinic agents are generally used in psychiatry to treat the extrapyramidal side effects of antipsychotic medications. However, these agents may have antidepressant and mood-elevating properties, and the literature suggests they are liable to abuse. The author reviews this literature and discusses its implication.
openaire   +2 more sources

Desethylaprophen: A Metabolite of Aprophen with Antimuscarinic Activities*

Journal of Pharmaceutical Sciences, 1988
The metabolic fate of aprophen hydrochloride (2-diethylaminoethyl 2,2-diphenylpropionate) was studied in rats after intravenous administration. Both 14C-labeled and unlabeled aprophen were used in these studies. Blood samples were collected and analyzed to determine the identities of the metabolites formed.
N D, Brown   +4 more
openaire   +2 more sources

Total synthesis of antimuscarinic alkaloid, (±)-TAN1251A

Tetrahedron, 2002
Abstract The total synthesis of (±)-TAN1251A possessing an antimuscarinic activity was achieved. Carboxylic acid ( 1 ) was converted into carbamate ( 3 ) through a sequence of alkylation and Curtius rearrangement. After a few functional group interconversions of 3 , the corresponding amine ( 9 ) was converted into an azaspiro molecule ( 18
Shinji Nagumo   +5 more
openaire   +1 more source

Preferences for antimuscarinic therapy for overactive bladder

BJU International, 2010
Study Type – Preference (discrete choice experiment) Level of Evidence 2a What’s known on the subject? and What does the study add? Whilst antimuscarinic treatments are widely used little work has been done to understand how patients consider the relative ...
Paul, Swinburn   +5 more
openaire   +2 more sources

Antimuscarinic drugs to treat overactive bladder

BMJ, 2012
A 45 year old woman presents to her general practitioner complaining of troublesome urinary symptoms increasingly affecting her quality of life. She is currently voiding more than 10 times a day and rising three times at night. In addition she notices a sudden urgent desire to void and on two occasions has leaked urine before reaching the toilet.
Dudley, Robinson, Linda, Cardozo
openaire   +2 more sources

Antimuscarinic drugs.

Methods and findings in experimental and clinical pharmacology, 1989
Anticholinergic, or antimuscarinic, drugs have been used for the treatment of more or less specified gastrointestinal diseases or complaints for many centuries, first in herbal preparations (including belladonna), and in modern times as synthetic tertiary or quaternary compounds, with atropine being a pharmacological standard.
openaire   +1 more source

Physostigmine for Antimuscarinic Toxicity

Journal of Emergency Nursing, 2020
Raghad Saadi, Kristin Bohnenberger
openaire   +2 more sources

Antimuscarinics and Cognitive Function

European Urology, 2006
In recent years antimuscarinics have been studied extensively after decades of silence. For many years oxybutynin formed the cornerstone of the treatment for overactive bladder (OAB). Currently, trospium chloride, tolterodine, solifenacin, and darifenacin have made it to the market.
openaire   +1 more source

Antimuscarinics in multiple sclerosis: A systematic review

Multiple Sclerosis and Related Disorders
Multiple sclerosis (MS) is an immune-mediated disease, impacting the central nervous system, resulting in a wide range of symptoms. Lower urinary tract symptoms (LUTS) are one of the common symptoms in MS patients and antimuscarinic drugs (AMs) are suggested as the first-line treatment in MS-related LUTS. This systematic review evaluates any impacts of
Afra Darvishi   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy